You sat in that office and described exactly what was happening. The itching. The patches that kept coming back. The skin that looked ashy no matter what you put on it. And the provider looked at you and said some version of "it's not that bad" — or handed you a basic moisturizer and sent you home.
You left feeling dismissed. Maybe you wondered if you were making it worse than it was.
You weren't. The system failed you. And there's a paper trail that proves it.
The Problem Starts With How Eczema Looks
You know how eczema is always described as a red, inflamed rash? That description was built around how it looks on lighter skin. On Black and Brown skin, eczema doesn't look red. It looks dark brown, purple, or ashen gray.
Most doctors are trained to spot eczema using photographs in textbooks and clinical references — and those images have historically shown lighter skin tones. So when a Black patient walks in with the same condition presenting differently, a provider without specific training in skin of color can look right at eczema and not recognize it.
It gets worse. The tools doctors use to measure how bad eczema is rely heavily on how much visible redness is present. On melanated skin, that redness is hidden beneath the surface. The result: the same level of inflammation that would be scored as moderate-to-severe on lighter skin can be scored as mild on darker skin — not because the condition is less serious, but because the measuring tool was never designed with your skin in mind.
What the Numbers Actually Show
This is not a feeling. This is documented.
A 2024 review found that severe eczema is six times more common in Black children than in white children. Despite having more severe disease, Black children are less likely to receive the medication they need — and more likely to end up in the emergency room because their condition wasn't caught and treated early enough.
A 2025 study found that Black infants waited significantly longer to see a dermatologist after their pediatrician flagged an eczema concern, compared to white infants. Not because of insurance alone. Because the system consistently underestimates how serious things are until they escalate.
Black children with eczema are also more likely to miss school because of their condition. That's what undertreated disease looks like in real life — not just in a chart.
The Textbook Problem Nobody Talks About
Here's one of the most straightforward reasons this keeps happening: the photographs doctors learn from don't show enough skin of color.
When a medical student or a family doctor learns to recognize eczema, they do it largely through images. If those images mostly show one skin tone, the doctor's eye gets trained on one skin tone. It's not always malicious — it's a gap in education that has been allowed to persist for decades.
As one dermatologist put it plainly in a peer-reviewed interview: even when Black patients seek care, doctors without specialized training tend to get it wrong because their education never showed them enough examples of how eczema actually presents on darker skin.
What Getting It Wrong Leaves Behind
A missed or delayed diagnosis isn't just frustrating. On melanated skin, it has a visible, lasting cost.
Every flare that goes unmanaged damages the skin barrier further. And every time the skin barrier breaks down on melanated skin, inflammation triggers more melanin production — leaving dark patches behind long after the flare itself is gone. Those patches can last months. Sometimes years.
By the time many Black patients finally get an accurate diagnosis, their eczema is more severe and harder to treat than it would have been with early care. The system's delay doesn't just cause discomfort — it leaves marks.
What You Can Do Right Now
Know what you're looking for. On melanated skin, eczema shows up as dark brown, purple, or ashen gray — not redness. Skin that looks persistently ashy, itches in the same spots repeatedly, or doesn't respond to regular moisturizing is telling you something.
Advocate for yourself specifically. If a provider is minimizing your symptoms, name the presentation directly — "my skin shows inflammation as discoloration, not redness" — and ask for a dermatology referral if general care isn't working.
Protect your barrier while you navigate the system. Daily barrier support limits the damage an undertreated condition causes over time. A clinically verified oil — one that holds the NEA Seal of Acceptance — is the most defensible daily tool you can use while you wait for the care you deserve.
Why Kiyamel Exists
Kiyamel was built because melanated skin has been an afterthought in both dermatology and skincare for too long. The misdiagnosis gap is part of what that looks like in the doctor's office. Products formulated without melanated skin in mind are part of what that looks like on the shelf.
The Kiyamel Eczema Relief Oil holds the National Eczema Association Seal of Acceptance — independently verified, clinically tested, and built specifically for the skin the industry has historically ignored.
Shop the Kiyamel Eczema Relief Oil →
Kiyamel products are not intended to diagnose, treat, cure, or prevent any disease. If you suspect you have eczema or another skin condition, consult a board-certified dermatologist.
